Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The Extended regimen (Mansoura University) is a preoperative antibiotic prophylaxis protocol developed for high-risk patients undergoing retrograde intrarenal surgery (RIRS) for renal stones. Evaluated in a Phase 3 clinical trial, the regimen primarily consists of a 7-day course of oral sulfamethoxazole-trimethoprim (TMP-SMX) administered twice daily, with the final dose given one day prior to the surgical intervention. In cases of patient allergy or documented bacterial resistance to TMP-SMX, the protocol utilizes alternative antibiotics such as nitrofurantoin, ciprofloxacin, or cefpodoxime. The regimen is designed to provide a prolonged duration of antimicrobial coverage to reduce the incidence of postoperative infectious complications, including systemic inflammatory response syndrome (SIRS) and urosepsis, which are significant risks in complex endourological procedures.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Extended regimen (Mansoura University).